Lecrolyn (Sodium Cromoglicate)

Sodium cromoglicate prevents mast cells in the conjunctiva from releasing histamine and other inflammatory mediators. By blocking this release, it limits the cascade that leads to vascular leakage, edema and nerve irritation, thereby alleviating the symptoms of allergic eye inflammation.

The dosing regimen for Lecrolyn is determined by the prescribing clinician based on the severity of the allergic eye condition and patient response. The prescriber will specify the number of drops, frequency and duration of treatment.

Safety data for sodium cromoglicate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To request Lecrolyn, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lecrolyn (sodium cromoglicate) is a mast cell stabiliser, whereas many other anti‑allergic eye drops are antihistamines or combination products. Mast cell stabilisers act upstream by preventing mediator release, offering a prophylactic approach, while antihistamines provide rapid symptom relief after exposure.

Lecrolyn should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from direct light and moisture, and discard any solution that appears discoloured or cloudy.

Lecrolyn is an ophthalmic solution applied as eye drops. The patient instils the prescribed number of drops into the affected eye(s) using a clean fingertip to lower the bottle, avoiding contact with the ocular surface, and follows any interval recommendations for other eye medications.

Although rare, serious adverse events can include severe allergic reactions such as anaphylaxis, persistent eye inflammation, corneal ulceration, or significant visual disturbances. Patients should seek immediate medical attention if they experience sudden swelling, pain, vision loss or signs of infection.

Lecrolyn is contraindicated in individuals with a known hypersensitivity to sodium cromoglicate or any component of the formulation. It should also be avoided in patients who cannot safely discontinue contact lens use during treatment or who have active severe ocular infections.